Engagement in care of high-risk hepatitis c patients with interferon-free direct-acting antiviral therapies, Dig Dis Sci, vol.62, pp.1472-1479, 2017. ,
Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting, BMC Public Health, vol.29, p.270, 2009. ,
Impact of hepatitis C treatment as prevention for people who inject drugs is sensitive to contact network structure, Sci Rep, vol.7, p.1833, 2017. ,
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients, J Viral Hepat, vol.15, pp.747-752, 2008. ,
Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels, J Infect Dis, vol.207, pp.19-25, 2013. ,
Engaging HIVHCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France), BMC Health Serv Res, vol.12, p.59, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00687514
Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.57, pp.118-124, 2013. ,